ARSAC notes for guidance: good clinical practice in nuclear medicine

Guidance on certification and best use of radiopharmaceuticals and sealed radioactive sources in diagnosis, treatment or research.


Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


This guidance to good clinical practice for nuclear medicine in the UK from the Administration of Radioactive Substances Advisory Committee (ARSAC) has been substantially updated since the 2017 edition to provide guidance on the licencing process under the Ionising Radiation (Medical Exposure) Regulations.

The notes include advice to help practitioners and employers fill in ARSAC application forms for the administration of radioactive substances for the purposes of diagnosis, therapy and research.

Additional information is also provided on the ARSAC approval process for research studies involving the administration of radioactive substances.

Published 17 April 2014
Last updated 30 January 2018 + show all updates
  1. Replaced 'notes for guidance' document and updated detail text.
  2. Uploaded the 2017 edition of guidance.
  3. January 2016 update to guidance.
  4. First published.